Integrative oncology in the Middle East: From traditional herbal knowledge to contemporary cancer care

Annals of Oncology

Volumn 23, Issue 1, 2012, Pages 211-221

  Ben Arye, E ^a,b   Schiff, E ^c,d   Hassan, E ^e   Mutafoglu, K ^f   Lev ari, S ^g   Steiner, M ^a   Lavie, O ^h   Polliack, A ⁱ   Silbermann, M ^j   Lev, E ^d  

^a CLALIT HEALTH SERVICES   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d UNIVERSITY OF HAIFA   (Israel)

^e NATIONAL RESEARCH CENTRE   (Egypt)

^f DOKUZ EYLUL UNIVERSITY   (Turkey)

^g TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^h CARMEL MEDICAL CENTER   (Israel)

ⁱ HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^j Middle East Cancer Consortium   (Israel)

more..

Author keywords

Cancer; Herbal medicine; Islamic medicine; Oncology; Traditional medicine

Indexed keywords

ALTHAEA OFFICINALIS EXTRACT; AMARANTHUS BLITUM EXTRACT; ANACYCLUS ANTHEMIS EXTRACT; ANCHUSA ITALICA EXTRACT; ANCHUSA OFFICINALIS EXTRACT; ANTINEOPLASTIC AGENT; ARUM DIOSCORIDES EXTRACT; BORTEZOMIB; BOSWELLIA CARTERI EXTRACT; BOSWELLIA SACRA EXTRACT; CEPHALIS IPECACUANHA EXTRACT; CERCIS SILIQUASTRUM EXTRACT; CINNAMOMUM CASSIA EXTRACT; CINNAMOMUM ZEYLANICUM EXTRACT; COLOCYNTH EXTRACT; COMMIPHORA MYRRHA EXTRACT; CONVOLVULUS SCAMMONIA EXTRACT; COSTUS SPECIOSUS EXTRACT; CROCUS SATIVUS EXTRACT; CURCUMA LONGA EXTRACT; CYPERUS LONGUS EXTRACT; CYPERUS ROTUNDUS EXTRACT; DRACAENA DRACO EXTRACT; FICUS CARICA EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; GREEN TEA EXTRACT; HERBACEOUS AGENT; LEMON EXTRACT; ONION EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALTHEA OFFICINALIS; AMARANTHUS BLITUM; ANACYCLUS ANTHEMIS; ANCHUSA ITALICA; ANCHUSA OFFICINALIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; ARUM DIOSCORIDES; BOSWELLIA CARTERI; BOSWELLIA SACRA; BREAST CANCER; CANCER RESEARCH; CEPHALIS IPECACUANHA; CERCIS SILIQUASTRUM; CINNAMOMUM CASSIA; CINNAMOMUM ZEYLANICUM; COLOCYNTH; COLORECTAL ADENOMA; COLORECTAL CANCER; COMMIPHORA MYRRHA; CONVOLVULUS SCAMMONIA; COSTUS SPECIOSUS; CROCUS SATIVUS; CURCUMA LONGA; CYPERUS LONGUS; CYPERUS ROTUNDUS; DIGESTIVE SYSTEM CANCER; DRACAENA DRACO; DRUG BIOAVAILABILITY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; ETHNOBOTANY; FIG; GLYCYRRHIZA GLABRA; HEALTH SURVEY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEMON; MEDICAL PRACTICE; MEDICINAL PLANT; MIDDLE EAST; MOUTH CANCER; NONHUMAN; ONCOLOGY; ONION; PANCREAS CANCER; PILOT STUDY; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROSTATE CANCER; SKIN CANCER; STOMACH CANCER; SYSTEMATIC REVIEW; TEA; TRADITIONAL MEDICINE; UTERINE CERVIX CANCER;

EID: 84855183973     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr054     Document Type: Article

References (145)

1. Noble RL. The discovery of the vinca alkaloids. chemotherapeutic agents against cancer. Biochem Cell Biol 1990; 68(12): 1344-1351.
2. Cragg GM, Boyd MR, Cardellina JH II et al. Ethnobotany and drug discovery: the experience of the US National Cancer Institute. Ciba Found Symp 1994; 185: 178-190; discussion 190.
3. Facchini PJ, De Luca V. Opium poppy and Madagascar periwinkle: model non-model systems to investigate alkaloid biosynthesis in plants. Plant J 2008; 54(4): 763-784.
4. Garodia P, Ichikawa H, Malani N et al. From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer. J Soc Integr Oncol 2007; 5(1): 25-37.
5. Ichikawa H, Nakamura Y, Kashiwada Y, Aggarwal BB. Anticancer drugs designed by mother nature: ancient drugs but modern targets. Curr Pharm Des 2007; 13(33): 3400-3416.
6. Lev E. Ethno-diversity within current ethno-pharmacology as part of Israeli traditional medicine. a review. J Ethnobiol Ethnomed 2006; 2: 4.
7. Weiss E, Kislev ME, Simchoni O et al. Plant-food preparation area on an Upper Paleolithic brush hut floor at Ohalo II, Israel. J Archaeol Sci 2008; 35: 2400-2414.
8. Lev E, Kislev ME, Bar-Yosef O. Mousterian vegetal food in Kebara Cave, Mt. Carmel. J Archaeol Sci 2005; 32: 475-484.
9. Yu F, Takahashi T, Moriya J et al. Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res 2006; 34(3): 231-239.
10. Pormann PE, Savage-Smith E. Medieval Islamic Medicine. Washington, DC: Georgetown University Press 2007.
11. Abū 'Alī al-Husayn Ibn Sīnā. Kitāb al-Qānūn fī al-Tibb. Bulaq 1877.
12. Lev E, Amar Z. Ethnopharmacological survey of traditional drugs sold in Israel at the end of the 20th century. J Ethnopharmacol 2000; 72: 191-205.
13. El-Obeid A, Al-Harbi S, Al-Jomah N, Hassib A. Herbal melanin modulates tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) production. Phytomedicine 2006; 13(5): 324-333.
14. Abuharfeil NM, Maraqa A, Von Kleist S. Augmentation of natural killer cell activity in vitro against tumor cells by wild plants from Jordan. J Ethnopharmacol 2000; 71(1-2): 55-63.
15. Salim EI, Fukushima S. Chemopreventive potential of volatile oil from black cumin (Nigella sativa L.) seeds against rat colon carcinogenesis. Nutr Cancer 2003; 45(2): 195-202.
16. Rubnov S, Kashman Y, Rabinowitz R et al. Suppressors of cancer cell proliferation from fig (Ficus carica) resin: isolation and structure elucidation. J Nat Prod 2001; 64(7): 993-996.
17. Lev-Ari S, Starr A, Vexler A et al. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Res 2006; 26(6B): 4423-4430.
18. Rajabalian S. Methanolic extract of Teucrium polium L. potentiates the cytotoxic and apoptotic effects of anticancer drugs of vincristine, vinblastine and doxorubicin against a panel of cancerous cell lines. Exp Oncol 2008; 30(2): 133-138.
19. Mothana RA, Lindequist U, Gruenert R, Bednarski PJ. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complement Altern Med 2009; 9: 7.
20. Kilani-Jaziri S, Neffati A, Limem I et al. Relationship correlation of antioxidant and antiproliferative capacity of Cyperus rotundus products towards K562 erythroleukemia cells. Chem Biol Interact 2009; 181(1): 85-94.
21. Turan N, Akgün-Dar K, Kuruca SE et al. Cytotoxic effects of leaf, stem and root extracts of Nerium oleander on leukemia cell lines and role of the pglycoprotein in this effect. J Exp Ther Oncol 2006; 6(1): 31-38.
22. Bar-Sela G, Tsalic M, Fried G, Goldberg H. Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study. Nutr Cancer 2007; 58(1): 43-48.
23. Yucel I, Guzin G. Topical henna for capecitabine induced hand-foot syndrome. Invest New Drugs 2008; 26(2): 189-192.
24. Ben-Arye E, Bar-Sela G, Frenkel M et al. Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality. Support Care Cancer 2006; 14(2): 147-152.
25. Ucan O, Pehlivan S, Ovayolu N et al. The use of complementary therapies in cancer patients: a questionnaire-based descriptive survey from southeastern Turkey. Am J Clin Oncol 2008; 31(6): 589-594.
26. Tarhan O, Alacacioglu A, Somali I et al. Complementary-alternative medicine among cancer patients in the western region of Turkey. J BUON 2009; 14(2): 265-269.
27. Lev E. Medicinal Substances of the Medieval Levant. Tel Aviv, Israel: Eretz publications 2002.
28. Ali-Shtayeh MS, Yaniv Z, Mahajna J. Ethnobotanical survey in the Palestinian area: a classification of the healing potential of medicinal plants. J Ethnopharmacol 2000; 73(1-2): 221-232.
29. Belman S. Onion and garlic oils inhibit tumor promotion. Carcinogenesis 1983; 4: 1063-1065.
30. Perchellet JP, Perchellet EM, Belman S. Inhibition of DMBA-induced mouse skin tumorigenesis by garlic oil and inhibition of two tumor-promotion stages by garlic and onion oils. Nutr Cancer 1990; 14: 183-193.
31. Challier B, Perarnau JM, Viel JF. Garlic, onion and cereal fibre as protective factors for breast cancer: a French case-control study. Eur J Epidemiol 1998; 14: 737-747.
32. Millen AE, Subar AF, Graubard BI et al. Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial. Am J Clin Nutr 2007; 86(6): 1754-1764.
33. Boeing H, Jedrychowski W, Wahrendorf J et al. Dietary risk factors in intestinal and diffuse types of stomach cancer: a multicenter case-control study in Poland. Cancer Causes Control 1991; 2(4): 227-233.
34. Grant WB. A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. Eur Urol 2004; 45(3): 271-279.
35. González CA, Pera G, Agudo A et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006; 118(10): 2559-2566.
36. Galeone C, Pelucchi C, Dal Maso L et al. Allium vegetables intake and endometrial cancer risk. Public Health Nutr 2009; 12(9): 1576-1579.
37. Rosner F, Muntner S. Studies in Judaica. The medical aphorisms of Moses Maimonides. New York: Yeshiva University Press 1970; 1: 267.
38. Frank MB, Yang Q, Osban J et al. Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity. BMC Complement Altern Med 2009; 9: 6.
39. Levey M. The Medical Formulary or the 'Aqrābādhīn of al-Kindī. Madison, WI 1966.
40. Sukumaran K, Kuttan R. Inhibition of tobacco-induced mutagenesis by eugenol and plant extracts. Mutat Res 1995; 343(1): 25-30.
41. Akihisa T, Tabata K, Banno N et al. Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri. Biol Pharm Bull. 2006; 29(9): 1976-1979.
42. El-Desouky SK, Kim KH, Ryu SY et al. A new pyrrole alkaloid isolated from Arum palaestinum Boiss. and its biological activities. Arch Pharm Res 2007; 30(8): 927-931.
43. Al-Qazwini Z, Adjab-al-Makhluqat. Beirut, Lebanon: Dar al-Sharq 1981; in Arabic.
44. Zhao W, Entschladen F, Liu H et al. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detect Prev 2003; 27(1): 67-75.
45. Madar Z, Raiany Y. Nutrition and Popular Remedy-Yemenite Tradition. Tel Aviv, Israel: Ministry of Defense.
46. Siddiqui IA, Malik A, Adhami VM et al. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 2008; 27(14): 2055-2063.
47. Cho KN, Sukhthankar M, Lee SH et al. Green tea catechin (-)-epicatechin gallate induces tumour suppressor protein ATF3 via EGR-1 activation. Eur J Cancer 2007; 43(16): 2404-2412.
48. Ahn WS, Yoo J, Huh SW et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 2003; 12(5): 383-390.
49. Halder A, Raychowdhury R, Ghosh A, De M. Black tea (Camellia sinensis) as a chemopreventive agent in oral precancerous lesions. J Environ Pathol Toxicol Oncol 2005; 24(2): 141-144.
50. Jatoi A, Ellison N, Burch PA et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003; 97(6): 1442-1446.
51. McLarty J, Bigelow RL, Smith M et al. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila) 2009; 2(7): 673-682.
52. Kurahashi N, Sasazuki S, Iwasaki M et al. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 2008; 167(1): 71-77.
53. Golden EB, Lam PY, Kardosh A et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009; 113(23): 5927-5937.
54. Abu-Rabia A. Traditional Bedouin Medicine. Tel Aviv, Israel: Ministry of Defense 1999.
55. Buchman Y, Amar Z. Practical Medicine of Rabbi Hayyim Vital (1543-1620): Healer in the Land of Israel and Vicinity. Tel Aviv, Israel: Unit of the History of Medicine 2006.
56. Kwon HK, Jeon WK, Hwang JS et al. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8+ T cells. Cancer Lett 2009; 278(2): 174-182.
57. Guess BW, Scholz MC, Strum SB et al. Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study. Prostate Cancer Prostatic Dis 2003; 6(4): 301-304.
58. El-Readi MZ, Hamdan D, Farrag N et al. Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. Eur J Pharmacol 2010; 626(2-3): 139-145.
59. Hung JY, Hsu YL, Ko YC et al. Didymin, a dietary flavonoid glycoside from citrus fruits, induces Fas-mediated apoptotic pathway in human non-smallcell lung cancer cells in vitro and in vivo. Lung Cancer 2009; 68(3): 366-374.
60. Hartwell JL. Plants used against cancer-a survey. Lloydia 1969; 32: 292.
61. Reiani Y. Medicinal substances of the Yemenite Jews. Unpublished MSc Thesis, Jerusalem, Israel The Hebrew University of Jerusalem 1963.
62. Tannin-Spitz T, Grossman S, Dovrat S et al. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem Pharmacol 2007; 73(1): 56-67.
63. Gebhardt R. Antioxidative, antiproliferative and biochemical effects in HepG2 cells of a homeopathic remedy and its constituent plant tinctures tested separately or in combination. Arzneimittelforschung 2003; 53(12): 823-830.
64. Shoemaker M, Hamilton B, Dairkee SH et al. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res 2005; 19(7): 649-651.
65. Meng XL, Riordan NH, Casciari JJ et al. Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. P R Health Sci J 2002; 21(4): 323-328.
66. Mothana RA, Gruenert R, Bednarski PJ, Lindequist U. Evaluation of the in vitro anticancer, antimicrobial and antioxidant activities of some Yemeni plants used in folk medicine. Pharmazie 2009; 64(4): 260-268.
67. Feizzadeh B, Afshari JT, Rakhshandeh H et al. Cytotoxic effect of saffron stigma aqueous extract on human transitional cell carcinoma and mouse fibroblast. Urol J 2008; 5(3): 161-167.
68. Tavakkol-Afshari J, Brook A, Mousavi SH. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol 2008; 46(11): 3443-3447.
69. Aung HH, Wang CZ, Ni M et al. Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol 2007; 29(3): 175-180.
70. Lev-Ari S, Strier L, Kazanov D et al. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 2005; 11(18): 6738-6744.
71. Sharma RA, McLelland HR, Hill KA et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001; 7(7): 1894-1900.
72. Dhillon N, Aggarwal BB, Newman RA et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008; 14(14): 4491-4499.
73. Lev-Ari S, Vexler A, Starr A et al. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 2007; 25(6): 411-418.
74. Martin L, Noury al-Khaledy. The Medical Formulary of al-Samarqandī. Philadelphia, PA: University of Pennsylvania Press, 1967.
75. Kilani S, Ledauphin J, Bouhlel I et al. Comparative study of Cyperus rotundus essential oil by a modified GC/MS analysis method. Evaluation of its antioxidant, cytotoxic, and apoptotic effects. Chem Biodivers 2008; 5(5): 729-742.
76. Hernández JC, León F, Quintana J et al. Icogenin, a new cytotoxic steroidal saponin isolated from Dracaena draco. Bioorg Med Chem 2004; 12(16): 4423-4429.
77. González AG, Hernández JC, León F et al. Steroidal saponins from the bark of Dracaena draco and their cytotoxic activities. J Nat Prod 2003; 66(6): 793-798.
78. Ullman SB. The inhibitory and necrosis-inducing effects of the latex of Ficus carica L. on transplanted and spontaneous tumours. Exp Med Surg 1952; 10(1): 26-49.
79. Amara AA, El-Masry MH, Bogdady HH. Plant crude extracts could be the solution: extracts showing in vivo antitumorigenic activity. Pak J Pharm Sci 2008; 21(2): 159-171.
80. Sheela ML, Ramakrishna MK, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol 2006; 6(3): 494-498.
81. Fu Y, Hsieh TC, Guo J et al. Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 2004; 322(1): 263-270.
82. Muntner S. (ed): Saladino d'Ascoli, Book of the Pharmacists (1430). Tel-Aviv, Israel: Machbaroth Lesifrut Publishing House 1963.
83. Jesse P, Mottke G, Eberle J et al. Apoptosis-inducing activity of Helleborus niger in ALL and AML. Pediatr Blood Cancer 2009; 52(4): 464-469.
84. McIntosh GH, Jorgensen L, Royle P. The potential of an insoluble dietary fiber-rich source from barley to protect from DMH-induced intestinal tumors in rats. Nutr Cancer 1993; 19(2): 213-221.
85. Kanauchi O, Mitsuyama K, Andoh A, Iwanaga T. Modulation of intestinal environment by prebiotic germinated barley foodstuff prevents chemo-induced colonic carcinogenesis in rats. Oncol Rep 2008; 20(4): 793-801.
86. Said HM, Elahie RE (eds): Al-Bīrūnī's Book on Pharmacy and Materia Medica. Karachi, Pakistan: Hamdard National Foundation 1973.
87. Loizzo MR, Tundis R, Menichini F et al. Cytotoxic activity of essential oils from labiatae and lauraceae families against in vitro human tumor models. Anticancer Res 2007; 27(5A): 3293-3299.
88. Hibasami H, Yamada Y, Moteki H et al. Sesquiterpenes (costunolide and zaluzanin D) isolated from laurel (Laurus nobilis L.) induce cell death and morphological change indicative of apoptotic chromatin condensation in leukemia HL-60 cells. Int J Mol Med 2003; 12(2): 147-151.
89. Kaileh M, Berghe WV, Boone E et al. Screening of indigenous Palestinian medicinal plants for potential anti-inflammatory and cytotoxic activity. J Ethnopharmacol 2007; 113(3): 510-516.
90. Ong CY, Ling SK, Ali RM et al. Systematic analysis of in vitro photo-cytotoxic activity in extracts from terrestrial plants in Peninsula Malaysia for photodynamic therapy. J Photochem Photobiol B 2009; 96(3): 216-222.
91. Smit HF, Woerdenbag HJ, Singh RH et al. Ayurvedic herbal drugs with possible cytostatic activity. J Ethnopharmacol 1995; 47(2): 75-84.
92. Kassie F, Rabot S, Uhl M et al. Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions. Carcinogenesis 2002; 23(7): 1155-1161.
93. Manna SK, Sah NK, Newman RA et al. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res 2000; 60(14): 3838-3847.
94. Mekhail T, Kaur H, Ganapathi R et al. Phase 1 trial of Anvirzel in patients with refractory solid tumors. Invest New Drugs 2006; 24(5): 423-427.
95. Banerjee S, Kaseb AO, Wang Z et al. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. Cancer Res 2009; 69(13): 5575-5583.
96. Shafi G, Munshi A, Hasan TN et al. Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa. Cancer Cell Int 2009; 9: 29.
97. Lamchouri F, Settaf A, Cherrah Y et al. Antitumour principles from Peganum harmala seeds. Therapie 1999; 54(6): 753-758.
98. Jahaniani F, Ebrahimi SA, Rahbar-Roshandel N, Mahmoudian M. Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent. Phytochemistry 2005; 66(13): 1581-1592.
99. Dornberger K. The potential antineoplastic acting constituents of Physalis alkekengi L. var franchetii Mast. Pharmazie 1986; 41(4): 265-268.
100. Ibn al-Bayţār. Kitāb al-Jāmiv li-Mufradāt al-'Adwiya wa-l-'Aghdhiya. Cairo 1874.
101. Balan KV, Prince J, Han Z et al. Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. var. chia. Phytomedicine 2007; 14(4): 263-272.
102. Batanouny, KH. Wild Medicinal Plants in Egypt: An Inventory to Support Conservation and Sustainable Use. Cairo, Egypt: Palm Press 1999.
103. López JC, Villanueva R, Martínez-Hernández D et al. Plantago ovata consumption and colorectal mortality in Spain, 1995-2000. J Epidemiol 2009; 19(4): 206-211.
104. Abou-Karam M, Shier WT. Inhibition of oncogene product enzyme activity as an approach to cancer chemoprevention. Tyrosine-specific protein kinase inhibition by purpurogallin from Quercus sp. nutgall. Phytother Res 1999; 13(4): 337-340.
105. Amar Z. Pri Megadim of Rabbi David de Silva. Jerusalem, Israel: Yad Yitzhak Ben-Zvi 2003.
106. Gali-Muhtasib HU, Affara NI. Chemopreventive effects of sage oil on skin papillomas in mice. Phytomedicine 2000; 7(2): 129-136.
107. Itani WS, El-Banna SH, Hassan SB et al. Anti colon cancer components from lebanese sage (Salvia libanotica) essential oil: mechanistic basis. Cancer Biol Ther 2008; 7(11): 1765-1773.
108. Drǎgan S, Nicola T, Ilina R et al. Role of multi-component functional foods in the complex treatment of patients with advanced breast cancer. Rev Med Chir Soc Med Nat Iasi 2007; 111(4): 877-884.
109. Dāwud al-,Anţākī. Tadhkirat ūlī al-'albāb wa-l-jāmi' li-l-'ajab al-'ujjāb. Cairo, Egypt: Dawud al-Antaki 1935.
110. Konrad L, Müller HH, Lenz C et al. Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract. Planta Med 2000; 66(1): 44-47.
111. Durak I, Biri H, Devrim E et al. Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in prostate tissue from patients with prostate cancer. Cancer Biol Ther 2004; 3(9): 855-857.
112. Agus HH, Tekin P, Bayav M, Semiz A, Sen A Drug interaction potential of the seed extract of Urtica urens L. (dwarf nettle). Phytother Res. 2009; 23(12): 1763-1770.
113. Khil LY, Kim W, Lyu S et al. Mechanisms involved in Korean mistletoe lectin-induced apoptosis of cancer cells. World J Gastroenterol 2007; 13(20): 2811-2818.
114. Valentiner U, Pfüller U, Baum C, Schumacher U. The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitro. Toxicology 2002; 171(2-3): 187-199.
115. Kovacs E. The in vitro effect of Viscum album (VA) extract on DNA repair of peripheral blood mononuclear cells (PBMC) in cancer patients. Phytother Res 2002; 16(2): 143-147.
116. Elluru SR, Van Huyen JP, Delignat S et al. Antiangiogenic properties of Viscum album extracts are associated with endothelial cytotoxicity. Anticancer Res 2009; 29(8): 2945-2950.
117. Urech K, Buessing A, Thalmann G et al. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines. Anticancer Res 2006; 26(4B): 3049-3055.
118. Elluru SR, Van Huyen JP, Delignat S et al. Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer. BMC Cancer 2008; 8: 161.
119. Huber R, Rostock M, Goedl R et al. Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects. Eur J Med Res 2005; 10(10): 411-418.
120. Kienle GS, Kiene H. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res 2007; 12: 103-119.
121. Horneber MA, Bueschel G, Huber R et al. Mistletoe therapy in oncology. Cochrane Database Syst Rev 2008; (2): CD003297.
122. Semiglazov VF, Stepula VV, Dudov A et al. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res 2006; 26(2B): 1519-1529.
123. Piao BK, Wang YX, Xie GR et al. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res 2004; 24(1): 303-309.
124. Bock PR, Friedel WE, Hanisch J et al. Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittelforschung 2004; 54(8): 456-466.
125. Klopp R, Schmidt W, Werner E et al. Influence of complementary Viscum album (Iscador) administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy. Anticancer Res 2005; 25(1B): 601-610.
126. Bar-Sela G, Goldberg H, Beck D et al. Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. Anticancer Res 2006; 26(1B): 709-713.
127. Enesel MB, Acalovschi I, Grosu V et al. Patient data meta-analysis of survival and psychosomatic self-regulation from published prospective controlled cohort studies for long-term therapy of breast cancer patients with a mistletoe preparation. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients. Anticancer Res 2005; 25(6C): 4583-4590.
128. Ziegler R, Grossarth-Maticek R. Individual patient data meta-analysis of survival and psychosomatic self-regulation from published prospective controlled cohort studies for long-term therapy of breast cancer patients with a mistletoe preparation (Iscador). Evid Based Complement Alternat Med 2010; 7(2): 157-166.
129. Grossarth-Maticek R, Ziegler R. Prospective controlled cohort studies on longterm therapy of cervical cancer patients with a mistletoe preparation (Iscador). Forsch Komplementmed 2007; 14(3): 140-147.
130. Grossarth-Maticek R, Ziegler R. Prospective controlled cohort studies on long-term therapy of ovarian cancer patients with mistletoe (Viscum album L.) extracts iscador. Arzneimittelforschung 2007; 57(10): 665-678.
131. Grossarth-Maticek R, Ziegler R. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador). Eur J Med Res 2008; 13(3): 107-120.
132. Cazacu M, Oniu T, Lungoci C et al. The influence of isorel on the advanced colorectal cancer. Cancer Biother Radiopharm 2003; 18(1): 27-34.
133. Augustin M, Bock PR, Hanisch J et al. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittelforschung 2005; 55(1): 38-49.
134. Elsässer-Beile U, Leiber C, Wetterauer U et al. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer. Anticancer Res 2005; 25(6C): 4733-4736.
135. Pae HO, Oh GS, Seo WG et al. Mistletoe lectin synergizes with paclitaxel in human SK-hep1 hepatocarcinoma cells. Immunopharmacol Immunotoxicol 2001; 23(4): 531-540.
136. Melzer J, Iten F, Hostanska K, Saller R. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forsch Komplementmed 2009; 16(4): 217-226.
137. Sáenz MT, Ahumada MC, García MD. Extracts from Viscum and Crataegus are cytotoxic against larynx cancer cells. Z Naturforsch C 1997; 52(1-2): 42-44.
138. Martín-Cordero C, López-Lázaro M, Agudo MA et al. A cytotoxic diarylheptanoid from Viscum cruciatum. Phytochemistry 2001; 58(4): 567-569.
139. Kaliora AC, Kountouri AM, Karathanos VT et al. Effect of Greek raisins (Vitis vinifera L.) from different origins on gastric cancer cell growth. Nutr Cancer 2008; 60(6): 792-799.
140. Amico V, Barresi V, Chillemi R et al. Bioassay-guided isolation of antiproliferative compounds from grape (Vitis vinifera) stems. Nat Prod Commun 2009; 4(1): 27-34.
141. Etheridge AS, Black SR, Patel PR et al. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med 2007; 73(8): 731-741.
142. Younes RN, Varella AD, Suffredii IB. Discovery of new antitumoral and antibacterial drugs from Brazilian plant extracts using high throughput screening. Clinics (Sao Paulo) 2007; 62(6): 763-768.
143. Konkimalla VB, Efferth T. Anti-cancer natural product library from traditional Chinese medicine. Comb Chem High Throughput Screen 2008; 11(1): 7-15.
144. Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2. Curr Oncol 2006; 13(3): 99-107.
145. Tilburt JC, Kaptchuk TJ. Herbal medicine research and global health: an ethical analysis. Bull World Health Organ 2008; 86: 594-599.